Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActice
Clinical trial NCT02719132 · WITHDRAWN
Trial details
- NCT number
- NCT02719132
- Sponsor
- AstraZeneca
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-11-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.